Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin/metformin in T2DM inadequately controlled with metformin
NCT01196546Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Mar 2010; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01196546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196546.